← Earnings Calendar
Coverage News Earnings Hub Grades Earnings Report
MNPR Q4 2026
Monopar Therapeutics Inc
Biotechnology
—
No Grade
🚀
Strong Beat
Actual $-0.46 vs Est $-0.85
+46.0%
📊 EPS Scorecard
EPS Estimate
$-0.85
EPS Actual
$-0.46
Surprise
+46.0%
Period2026-03-31
QuarterQ4 2026
📈 EPS Momentum — Last 4 Quarters
$-0.35
25-06
$-0.48
25-09
$-0.64
25-12
$-0.46
26-03
📉 -31% over 4 quarters
🤖 ESEN AI Grade Reasoning
🔒 AI Grade Reasoning Unlock with PLUS
🔗 Other MNPR Earnings
MNPR
Q1 2026
→ View
MNPR
Q2 2026
→ View
MNPR
Q3 2026
→ View
MNPR
Full Research
→ Stock Page
Unlock Full Earnings Analysis
AI grade reasoning, momentum alerts, and full analysis for 5,000+ stocks
Start PLUS — First Month $4.99
Then $19.99/month · Cancel anytime